Glimet Tablet 50/1000mg
Sitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
MFDS item code 201505749 · Approved 2015.08.18
This product's status changed to Expired on 2025.08.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood glucose control in patients with type 2 diabetes
This medication helps blood sugar control in patients with type 2 diabetes through the combined administration of sitagliptin and metformin. It is effective as an adjunctive therapy for patients undergoing dietary and exercise regimens to improve blood sugar levels.
For antidiabetic therapy, the dose of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: sitagliptin 100 mg and metformin 2000 mg. This drug is generally taken twice daily with food. The dose should be increased gradually to reduce gastrointestinal adverse reactions caused by metformin. The starting dose of this drug should be determined based on the patient's current treatment regimen. 1. Patients not currently receiving metformin: For patients with no prior experience of antidiabetic drug therapy whose blood glucose is not adequately controlled with monotherapy, or whose blood glucose cannot be adequately controlled with sitagliptin monotherapy, the starting dose of this drug is 1 tablet of 50/500 mg twice daily; the dose may be increased to 1 tablet of 50/1000 mg twice daily. Patients with renal impairment who are receiving a reduced dose of sitagliptin should not be switched to this drug (see Precautions for Use, 2. Patients Who Should Not Receive This Drug). 2. Patients receiving metformin: - For patients whose blood glucose is not adequately controlled with metformin monotherapy, the recommended starting dose of this drug is sitagliptin 50 mg twice daily (total daily dose 100 mg) and the patient's current metformin dose. - Patients switching to this drug from concomitant sitagliptin and metformin therapy may start at their current doses of sitagliptin and metformin. 3. Patients whose blood glucose is not adequately controlled with concomitant metformin and sulfonylurea, metformin and insulin, or metformin and thiazolidinedione therapy: The starting dose of this drug is sitagliptin 50 mg twice daily (total daily dose 100 mg), and the starting dose of metformin should be determined based on the patient's blood glucose level and current dose. The dose should be increased gradually to reduce gastrointestinal adverse reactions caused by metformin. When used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). No studies have been conducted to evaluate the safety and efficacy of switching to this drug in patients previously treated with another oral antidiabetic drug. Since any change in the treatment regimen for type 2 diabetes may result in changes in blood glucose control, caution should be exercised and appropriate monitoring should be performed. Patients with renal impairment This drug may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] ≥ 45 and < 60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 and < 60 mL/min/1.73m2), who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. Since the starting dose of metformin is 500 mg or 850 mg once daily, treatment should not be initiated with this drug. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 mL/min or eGFR < 45 mL/min/1.73m2, this drug should be discontinued immediately. Patients with hepatic impairment This drug should not be administered to patients with hepatic impairment because it contains metformin (see Precautions for Use, 2. Patients Who Should Not Receive This Drug).
This medication contains both sitagliptin and metformin and is used for the treatment of type 2 diabetes. Firstly, sitagliptin helps to manage blood sugar levels, but can rarely cause severe allergic reactions or skin disorders. If any of these symptoms occur, discontinue use immediately and consult a doctor. Additionally, there is a possibility of developing pancreatitis, so careful observation is needed if symptoms like abdominal pain or vomiting arise during use. Metformin is effective in lowering blood sugar but can rarely cause lactic acidosis, a serious metabolic disorder. This condition is accompanied by symptoms such as muscle pain, fatigue, and difficulty breathing; thus, if these symptoms occur, inform healthcare professionals immediately. Moreover, this medication should not be used by patients with impaired renal function or liver dysfunction. This medication is not for use in patients with reduced renal function, severe infections, dehydrated patients, patients with congestive heart failure, those undergoing specific contrast examinations, or women who are pregnant or breastfeeding. It is also advisable for children under 18 years or patients with certain metabolic disorders to avoid this medication. During treatment, irregular eating habits, intense exercise, and interactions with other medications may increase the risk of hypoglycemia or lactic acidosis, so caution is needed. In particular, when taken alongside insulin or sulfonylureas, the risk of hypoglycemia rises, necessitating frequent blood sugar monitoring and possible dosage adjustments. While taking this medication, it is important to regularly check renal function, blood tests, and vitamin B12 levels, and it is advisable to avoid alcohol consumption. Furthermore, it may be necessary to temporarily discontinue the medication before and after surgery, so consult with healthcare professionals. Rarely, severe joint pain, skin disorders, acute pancreatitis, and acute renal failure have been reported, so if any unusual symptoms occur, inform a doctor immediately. In case of overdose, visit a medical facility immediately for appropriate treatment, and blood dialysis may be considered if necessary. It is crucial that patients and their families fully understand the effects and side effects of the medication before and after taking it, alongside maintaining regular blood sugar management and improving lifestyle habits.
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly sealed container that is air-tight and stored at room temperature between 1 degree Celsius and 30 degrees Celsius. This will help maintain its effectiveness and prevent deterioration.
Dark red oval film-coated tablet
56 tablets (28 tablets/PTP*2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkun Dang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
Jong Kun Dang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
JongKeunDang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Sitagliptin Phosphate 62.04mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.